CompletedOBSERVATIONAL
A Prospective Virtual Study to Evaluate the Longevity of IgG Antibodies in Individuals Exposed to COVID-19
- Sponsor:
- Everly Health
- Conditions:
- SARS-CoV-2 Acute Respiratory Disease
- Enrollment:
- 1,883
- Started:
- Mar 2021
NCT05042193
Human trials
Where longevity science meets human data: registered trials of aging interventions, pulled daily from ClinicalTrials.gov. Status, phase, sponsor, and enrollment for each.
NCT05042193
NCT03917667
NCT02692612
NCT00717132
NCT03039647
NCT02626949
NCT05342272
NCT05326841
NCT03330509
NCT02550470
NCT03872375
NCT02817074
NCT03649802
NCT04314011
NCT04981587
NCT04281654
NCT03224988
NCT01787682
NCT03666624
NCT04354922
NCT04612283
NCT03759951
NCT04210869
NCT02523274
Literature and preprints via Europe PMC. Trial data from ClinicalTrials.gov, courtesy of the U.S. National Library of Medicine. We store metadata and abstracts and link to every source record. This is educational information, not medical advice.